Tear Glucose Sensor
Glucose Monitoring for Type 1 & Type 2 Diabetes
Phase 2Active
Key Facts
About Noviosense
Noviosense is pioneering a novel approach to glucose monitoring by developing a tear-based sensor designed to sit comfortably behind the lower eyelid. The company has successfully completed a Phase 2 clinical trial demonstrating correlation between tear and blood glucose and has initiated a second validation study in type 1 diabetics. Founded in 2016 and backed by venture capital, Noviosense is seeking strategic partners and funding to accelerate development toward a targeted market entry, positioning itself to disrupt the large and growing diabetes management market with a truly non-invasive solution.
View full company profile